HomeRZONF • OTCMKTS
add
Rize Oncology Ord Shs
Previous close
$0.16
Market cap
2.27M CAD
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 367.05K | 172.01% |
Net income | -369.97K | -187.40% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 151.85K | -84.28% |
Total assets | 277.99K | -72.64% |
Total liabilities | 6.75K | -77.07% |
Total equity | 271.24K | — |
Shares outstanding | 80.74M | — |
Price to book | ∞ | — |
Return on assets | -196.01% | — |
Return on capital | -199.33% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -369.97K | -187.40% |
Cash from operations | -296.71K | -275.71% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -308.52K | -373.83% |
Free cash flow | -148.12K | -328.45% |
About
Founded
2018
Headquarters
Website
